1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Active Pharmaceutical Ingredients Market, By Types of API
5.1 Introduction
5.2 Synthetic chemical API
5.2.1 Branded/ Innovative
5.2.2 Generic/Non- Branded
5.3 Biological API
5.3.1 Biotech
5.3.2 Biosimilar
5.4 High potency active pharmaceutical ingredients(HPAPI)

6 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturing
6.1 Introduction
6.2 Captive (or in-house) manufacturing
6.3 Contract manufacturing

7 Global Active Pharmaceutical Ingredients Market, By Therapeutic Application
7.1 Introduction
7.2 Anti-Infectives
7.3 Cardiovascular and hematopoietic system
7.4 CNS and Neurological Disorders
7.5 Diabetes
7.6 Endocrinology
7.7 Gastrointestinal disorder
7.8 Hormonal-related disorder
7.9 Metabolic disorder
7.10 Musculoskeletal disorder
7.11 Nephrology
7.12 Oncology
7.13 Ophthalmology
7.14 Orthopedic Disorders
7.15 Pulmonology

8 Global Active Pharmaceutical Ingredients Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Bioniche Animal Health (Canada)
10.2 Boehringer Ingelheim (Germany)
10.3 Sun Pharmaceutical Industries Ltd.
10.4 Teva Pharmaceutical Industries Limited
10.5 Bayer Healthcare (Germany)
10.6 Merial Inc. (Sanofi) (France)
10.7 Elanco Animal Health (U.S.)
10.8 Merck Animal Health (U.S.)
10.9 Ceva Animal Health, Inc.
10.10 Dr. Reddy’s Laboratories Ltd.
10.11 Novartis International AG
10.12 Ranbaxy Laboratories
10.13 Virbac
10.14 Zoetis (U.S.)
10.15 Pfizer, Inc
10.16 Aurobindo Pharma Ltd.
10.17 Heska Co. (U.S.)

List of Tables
Table 1 Global Active Pharmaceutical Ingredients Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Active Pharmaceutical Ingredients Market Outlook, By Types of API (2013-2022) ($MN)
Table 3 Global Active Pharmaceutical Ingredients Market Outlook, By Synthetic chemical API (2013-2022) ($MN)
Table 4 Global Active Pharmaceutical Ingredients Market Outlook, By Branded/ Innovative (2013-2022) ($MN)
Table 5 Global Active Pharmaceutical Ingredients Market Outlook, By Generic/Non- Branded (2013-2022) ($MN)
Table 6 Global Active Pharmaceutical Ingredients Market Outlook, By Biological API (2013-2022) ($MN)
Table 7 Global Active Pharmaceutical Ingredients Market Outlook, By Biotech (2013-2022) ($MN)
Table 8 Global Active Pharmaceutical Ingredients Market Outlook, By Biosimilar (2013-2022) ($MN)
Table 9 Global Active Pharmaceutical Ingredients Market Outlook, By High potency active pharmaceutical ingredients(HPAPI) (2013-2022) ($MN)
Table 10 Global Active Pharmaceutical Ingredients Market Outlook, By Type of manufacturing (2013-2022) ($MN)
Table 11 Global Active Pharmaceutical Ingredients Market Outlook, By Captive (or in-house) manufacturing (2013-2022) ($MN)
Table 12 Global Active Pharmaceutical Ingredients Market Outlook, By Contract manufacturing (2013-2022) ($MN)
Table 13 Global Active Pharmaceutical Ingredients Market Outlook, By Therapeutic applications (2013-2022) ($MN)
Table 14 Global Active Pharmaceutical Ingredients Market Outlook, By Anti-Infectives (2013-2022) ($MN)
Table 15 Global Active Pharmaceutical Ingredients Market Outlook, By Cardiovascular and hematopoietic system (2013-2022) ($MN)
Table 16 Global Active Pharmaceutical Ingredients Market Outlook, By CNS and Neurological Disorders (2013-2022) ($MN)
Table 17 Global Active Pharmaceutical Ingredients Market Outlook, By Diabetes (2013-2022) ($MN)
Table 18 Global Active Pharmaceutical Ingredients Market Outlook, By Endocrinology (2013-2022) ($MN)
Table 19 Global Active Pharmaceutical Ingredients Market Outlook, By Gastrointestinal disorder (2013-2022) ($MN)
Table 20 Global Active Pharmaceutical Ingredients Market Outlook, By Hormonal-related disorder (2013-2022) ($MN)
Table 21 Global Active Pharmaceutical Ingredients Market Outlook, By Metabolic disorder (2013-2022) ($MN)
Table 22 Global Active Pharmaceutical Ingredients Market Outlook, By Musculoskeletal disorder (2013-2022) ($MN)
Table 23 Global Active Pharmaceutical Ingredients Market Outlook, By Nephrology (2013-2022) ($MN)
Table 24 Global Active Pharmaceutical Ingredients Market Outlook, By Oncology (2013-2022) ($MN)
Table 25 Global Active Pharmaceutical Ingredients Market Outlook, By Ophthalmology (2013-2022) ($MN)
Table 26 Global Active Pharmaceutical Ingredients Market Outlook, By Orthopedic Disorders (2013-2022) ($MN)
Table 27 Global Active Pharmaceutical Ingredients Market Outlook, By Pulmonology (2013-2022) ($MN)
Table 28 North America Active Pharmaceutical Ingredients Market Outlook, By Country (2013-2022) ($MN)
Table 29 North America Active Pharmaceutical Ingredients Market Outlook, By Types of API (2013-2022) ($MN)
Table 30 North America Active Pharmaceutical Ingredients Market Outlook, By Synthetic chemical API (2013-2022) ($MN)
Table 31 North America Active Pharmaceutical Ingredients Market Outlook, By Branded/ Innovative (2013-2022) ($MN)
Table 32 North America Active Pharmaceutical Ingredients Market Outlook, By Generic/Non- Branded (2013-2022) ($MN)
Table 33 North America Active Pharmaceutical Ingredients Market Outlook, By Biological API (2013-2022) ($MN)
Table 34 North America Active Pharmaceutical Ingredients Market Outlook, By Biotech (2013-2022) ($MN)
Table 35 North America Active Pharmaceutical Ingredients Market Outlook, By Biosimilar (2013-2022) ($MN)
Table 36 North America Active Pharmaceutical Ingredients Market Outlook, By High potency active pharmaceutical ingredients(HPAPI) (2013-2022) ($MN)
Table 37 North America Active Pharmaceutical Ingredients Market Outlook, By Type of manufacturing (2013-2022) ($MN)
Table 38 North America Active Pharmaceutical Ingredients Market Outlook, By Captive (or in-house) manufacturing (2013-2022) ($MN)
Table 39 North America Active Pharmaceutical Ingredients Market Outlook, By Contract manufacturing (2013-2022) ($MN)
Table 40 North America Active Pharmaceutical Ingredients Market Outlook, By Therapeutic applications (2013-2022) ($MN)
Table 41 North America Active Pharmaceutical Ingredients Market Outlook, By Anti-Infectives (2013-2022) ($MN)
Table 42 North America Active Pharmaceutical Ingredients Market Outlook, By Cardiovascular and hematopoietic system (2013-2022) ($MN)
Table 43 North America Active Pharmaceutical Ingredients Market Outlook, By CNS and Neurological Disorders (2013-2022) ($MN)
Table 44 North America Active Pharmaceutical Ingredients Market Outlook, By Diabetes (2013-2022) ($MN)
Table 45 North America Active Pharmaceutical Ingredients Market Outlook, By Endocrinology (2013-2022) ($MN)
Table 46 North America Active Pharmaceutical Ingredients Market Outlook, By Gastrointestinal disorder (2013-2022) ($MN)
Table 47 North America Active Pharmaceutical Ingredients Market Outlook, By Hormonal-related disorder (2013-2022) ($MN)
Table 48 North America Active Pharmaceutical Ingredients Market Outlook, By Metabolic disorder (2013-2022) ($MN)
Table 49 North America Active Pharmaceutical Ingredients Market Outlook, By Musculoskeletal disorder (2013-2022) ($MN)
Table 50 North America Active Pharmaceutical Ingredients Market Outlook, By Nephrology (2013-2022) ($MN)
Table 51 North America Active Pharmaceutical Ingredients Market Outlook, By Oncology (2013-2022) ($MN)
Table 52 North America Active Pharmaceutical Ingredients Market Outlook, By Ophthalmology (2013-2022) ($MN)
Table 53 North America Active Pharmaceutical Ingredients Market Outlook, By Orthopedic Disorders (2013-2022) ($MN)
Table 54 North America Active Pharmaceutical Ingredients Market Outlook, By Pulmonology (2013-2022) ($MN)
Table 55 Europe Active Pharmaceutical Ingredients Market Outlook, By Country (2013-2022) ($MN)
Table 56 Europe Active Pharmaceutical Ingredients Market Outlook, By Types of API (2013-2022) ($MN)
Table 57 Europe Active Pharmaceutical Ingredients Market Outlook, By Synthetic chemical API (2013-2022) ($MN)
Table 58 Europe Active Pharmaceutical Ingredients Market Outlook, By Branded/ Innovative (2013-2022) ($MN)
Table 59 Europe Active Pharmaceutical Ingredients Market Outlook, By Generic/Non- Branded (2013-2022) ($MN)
Table 60 Europe Active Pharmaceutical Ingredients Market Outlook, By Biological API (2013-2022) ($MN)
Table 61 Europe Active Pharmaceutical Ingredients Market Outlook, By Biotech (2013-2022) ($MN)
Table 62 Europe Active Pharmaceutical Ingredients Market Outlook, By Biosimilar (2013-2022) ($MN)
Table 63 Europe Active Pharmaceutical Ingredients Market Outlook, By High potency active pharmaceutical ingredients(HPAPI) (2013-2022) ($MN)
Table 64 Europe Active Pharmaceutical Ingredients Market Outlook, By Type of manufacturing (2013-2022) ($MN)
Table 65 Europe Active Pharmaceutical Ingredients Market Outlook, By Captive (or in-house) manufacturing (2013-2022) ($MN)
Table 66 Europe Active Pharmaceutical Ingredients Market Outlook, By Contract manufacturing (2013-2022) ($MN)
Table 67 Europe Active Pharmaceutical Ingredients Market Outlook, By Therapeutic applications (2013-2022) ($MN)
Table 68 Europe Active Pharmaceutical Ingredients Market Outlook, By Anti-Infectives (2013-2022) ($MN)
Table 69 Europe Active Pharmaceutical Ingredients Market Outlook, By Cardiovascular and hematopoietic system (2013-2022) ($MN)
Table 70 Europe Active Pharmaceutical Ingredients Market Outlook, By CNS and Neurological Disorders (2013-2022) ($MN)
Table 71 Europe Active Pharmaceutical Ingredients Market Outlook, By Diabetes (2013-2022) ($MN)
Table 72 Europe Active Pharmaceutical Ingredients Market Outlook, By Endocrinology (2013-2022) ($MN)
Table 73 Europe Active Pharmaceutical Ingredients Market Outlook, By Gastrointestinal disorder (2013-2022) ($MN)
Table 74 Europe Active Pharmaceutical Ingredients Market Outlook, By Hormonal-related disorder (2013-2022) ($MN)
Table 75 Europe Active Pharmaceutical Ingredients Market Outlook, By Metabolic disorder (2013-2022) ($MN)
Table 76 Europe Active Pharmaceutical Ingredients Market Outlook, By Musculoskeletal disorder (2013-2022) ($MN)
Table 77 Europe Active Pharmaceutical Ingredients Market Outlook, By Nephrology (2013-2022) ($MN)
Table 78 Europe Active Pharmaceutical Ingredients Market Outlook, By Oncology (2013-2022) ($MN)
Table 79 Europe Active Pharmaceutical Ingredients Market Outlook, By Ophthalmology (2013-2022) ($MN)
Table 80 Europe Active Pharmaceutical Ingredients Market Outlook, By Orthopedic Disorders (2013-2022) ($MN)
Table 81 Europe Active Pharmaceutical Ingredients Market Outlook, By Pulmonology (2013-2022) ($MN)
Table 82 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Country (2013-2022) ($MN)
Table 83 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Types of API (2013-2022) ($MN)
Table 84 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Synthetic chemical API (2013-2022) ($MN)
Table 85 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Branded/ Innovative (2013-2022) ($MN)
Table 86 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Generic/Non- Branded (2013-2022) ($MN)
Table 87 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Biological API (2013-2022) ($MN)
Table 88 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Biotech (2013-2022) ($MN)
Table 89 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Biosimilar (2013-2022) ($MN)
Table 90 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By High potency active pharmaceutical ingredients(HPAPI) (2013-2022) ($MN)
Table 91 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Type of manufacturing (2013-2022) ($MN)
Table 92 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Captive (or in-house) manufacturing (2013-2022) ($MN)
Table 93 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Contract manufacturing (2013-2022) ($MN)
Table 94 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Therapeutic applications (2013-2022) ($MN)
Table 95 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Anti-Infectives (2013-2022) ($MN)
Table 96 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Cardiovascular and hematopoietic system (2013-2022) ($MN)
Table 97 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By CNS and Neurological Disorders (2013-2022) ($MN)
Table 98 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Diabetes (2013-2022) ($MN)
Table 99 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Endocrinology (2013-2022) ($MN)
Table 100 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Gastrointestinal disorder (2013-2022) ($MN)
Table 101 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Hormonal-related disorder (2013-2022) ($MN)
Table 102 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Metabolic disorder (2013-2022) ($MN)
Table 103 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Musculoskeletal disorder (2013-2022) ($MN)
Table 104 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Nephrology (2013-2022) ($MN)
Table 105 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Oncology (2013-2022) ($MN)
Table 106 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Ophthalmology (2013-2022) ($MN)
Table 107 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Orthopedic Disorders (2013-2022) ($MN)
Table 108 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Pulmonology (2013-2022) ($MN)
Table 109 RoW Active Pharmaceutical Ingredients Market Outlook, By Country (2013-2022) ($MN)
Table 110 RoW Active Pharmaceutical Ingredients Market Outlook, By Types of API (2013-2022) ($MN)
Table 111 RoW Active Pharmaceutical Ingredients Market Outlook, By Synthetic chemical API (2013-2022) ($MN)
Table 112 RoW Active Pharmaceutical Ingredients Market Outlook, By Branded/ Innovative (2013-2022) ($MN)
Table 113 RoW Active Pharmaceutical Ingredients Market Outlook, By Generic/Non- Branded (2013-2022) ($MN)
Table 114 RoW Active Pharmaceutical Ingredients Market Outlook, By Biological API (2013-2022) ($MN)
Table 115 RoW Active Pharmaceutical Ingredients Market Outlook, By Biotech (2013-2022) ($MN)
Table 116 RoW Active Pharmaceutical Ingredients Market Outlook, By Biosimilar (2013-2022) ($MN)
Table 117 RoW Active Pharmaceutical Ingredients Market Outlook, By High potency active pharmaceutical ingredients(HPAPI) (2013-2022) ($MN)
Table 118 RoW Active Pharmaceutical Ingredients Market Outlook, By Type of manufacturing (2013-2022) ($MN)
Table 119 RoW Active Pharmaceutical Ingredients Market Outlook, By Captive (or in-house) manufacturing (2013-2022) ($MN)
Table 120 RoW Active Pharmaceutical Ingredients Market Outlook, By Contract manufacturing (2013-2022) ($MN)
Table 121 RoW Active Pharmaceutical Ingredients Market Outlook, By Therapeutic applications (2013-2022) ($MN)
Table 122 RoW Active Pharmaceutical Ingredients Market Outlook, By Anti-Infectives (2013-2022) ($MN)
Table 123 RoW Active Pharmaceutical Ingredients Market Outlook, By Cardiovascular and hematopoietic system (2013-2022) ($MN)
Table 124 RoW Active Pharmaceutical Ingredients Market Outlook, By CNS and Neurological Disorders (2013-2022) ($MN)
Table 125 RoW Active Pharmaceutical Ingredients Market Outlook, By Diabetes (2013-2022) ($MN)
Table 126 RoW Active Pharmaceutical Ingredients Market Outlook, By Endocrinology (2013-2022) ($MN)
Table 127 RoW Active Pharmaceutical Ingredients Market Outlook, By Gastrointestinal disorder (2013-2022) ($MN)
Table 128 RoW Active Pharmaceutical Ingredients Market Outlook, By Hormonal-related disorder (2013-2022) ($MN)
Table 129 RoW Active Pharmaceutical Ingredients Market Outlook, By Metabolic disorder (2013-2022) ($MN)
Table 130 RoW Active Pharmaceutical Ingredients Market Outlook, By Musculoskeletal disorder (2013-2022) ($MN)
Table 131 RoW Active Pharmaceutical Ingredients Market Outlook, By Nephrology (2013-2022) ($MN)
Table 132 RoW Active Pharmaceutical Ingredients Market Outlook, By Oncology (2013-2022) ($MN)
Table 133 RoW Active Pharmaceutical Ingredients Market Outlook, By Ophthalmology (2013-2022) ($MN)
Table 134 RoW Active Pharmaceutical Ingredients Market Outlook, By Orthopedic Disorders (2013-2022) ($MN)
Table 135 RoW Active Pharmaceutical Ingredients Market Outlook, By Pulmonology (2013-2022) ($MN)